These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15123344)

  • 21. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
    Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
    Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
    Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
    Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy.
    Chui DH; Tabira T; Izumi S; Koya G; Ogata J
    Am J Pathol; 1994 Oct; 145(4):771-5. PubMed ID: 7943169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.
    Arena JD; Smith DH; Lee EB; Gibbons GS; Irwin DJ; Robinson JL; Lee VM; Trojanowski JQ; Stewart W; Johnson VE
    Brain; 2020 May; 143(5):1572-1587. PubMed ID: 32390044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer's disease--comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Shibuya K; Nakamura A; Yagishita S
    Acta Neuropathol; 2005 Mar; 109(3):299-305. PubMed ID: 15619127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
    Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective deposition of 4-repeat tau in cerebral infarcts.
    Ichihara K; Uchihara T; Nakamura A; Suzuki Y; Mizutani T
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1029-36. PubMed ID: 19680140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
    van de Nes JA; Sandmann-Keil D; Braak H
    Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between glial fibrillary acidic protein-positive astrocytes and age in the human hippocampus.
    Takahashi T; Amano N; Asamura H; Nomiyama T; Hanihara T; Nakayama J; Fukushima H
    Leg Med (Tokyo); 2006 May; 8(3):161-5. PubMed ID: 16621651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Oide T; Kinoshita T; Arima K
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau-2 immunoreactivity of corpora amylacea in the human retina and optic nerve.
    Loeffler KU; Edward DP; Tso MO
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2600-3. PubMed ID: 7686896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
    Grudzien A; Shaw P; Weintraub S; Bigio E; Mash DC; Mesulam MM
    Neurobiol Aging; 2007 Mar; 28(3):327-35. PubMed ID: 16574280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histologic study of age-related change in the posterior pituitary gland focusing on abnormal deposition of tau protein.
    Hashizume M; Takagi J; Kanehira T; Otake K; Mimuro M; Yoshida M; Hashizume Y
    Pathol Int; 2011 Jan; 61(1):13-8. PubMed ID: 21166938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.
    Braak E; Braak H; Mandelkow EM
    Acta Neuropathol; 1994; 87(6):554-67. PubMed ID: 7522386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
    Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
    Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain.
    Korolainen MA; Auriola S; Nyman TA; Alafuzoff I; Pirttilä T
    Neurobiol Dis; 2005 Dec; 20(3):858-70. PubMed ID: 15979880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.
    Fujino Y; Wang DS; Thomas N; Espinoza M; Davies P; Dickson DW
    J Neuropathol Exp Neurol; 2005 Mar; 64(3):209-14. PubMed ID: 15804052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort.
    Lace G; Ince PG; Brayne C; Savva GM; Matthews FE; de Silva R; Simpson JE; Wharton SB
    Dement Geriatr Cogn Disord; 2012; 34(1):15-24. PubMed ID: 22868294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.